TrialNatrunix or Placebo in Combination With Methotrexate in Rheumatoid Arthritis
Trial details
- Registry ID
- NCT05363891
- Phase
- Phase 2
Drug research
Natrunix
Open a linked trial to see its study details and recorded changes, or check the regulatory events below and follow their sources.
Drug identity checked against registry records
Also recorded as True Human IgG4 monoclonal antibody
A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.
Included trials
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| Natrunix or Placebo in Combination With Methotrexate in Rheumatoid ArthritisNCT05363891 | XBIT | Phase 2 | Completed | 2024-10-31Actual |
Regulatory dates and decisions
| No regulatory events match this view.Try another date range or view. Events appear after automated source checks. This does not mean no FDA events have occurred. Dates that a source does not disclose stay undisclosed. |